Upregulation of AQP4 expression levels was previously described upon neuroinflammation in neurodegenerative diseases, such as Alzheimer's disease (50) and multiple sclerosis (51). This evidence concerns the gene AQP4 and early-onset autosomal dominant Alzheimer disease.